Remab Therapeutics
Developing a pipeline with different indications.
Launch date
Employees
Company register number B67210021
L'Hospitalet de Llobregat Catalonia (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m |
| % growth | - | 198 % | 227 % | 17 % |
| EBITDA | - | <1m | <1m | <1m |
| % EBITDA margin | - | 7 % | 7 % | 9 % |
| Profit | - | - | - | (<1m) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
€70.0k | Grant | ||
N/A | Spinout | ||
€35.0k | Grant | ||
€50.0k | Grant | ||
| Total Funding | $171k | ||
Related Content
Recent News about Remab Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.